ProFound Therapeutics
United States · $333.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- profoundtx.com
- Total Funding
- $333.0M
- Last Round
- $100.0M Series BMay 2026
- Rounds
- 4
About
Biotech company pioneering discovery of an expanded human proteome to develop new medicines for cancer and other diseases.
Summary
ProFound Therapeutics is a Biotech company based in United States. It has raised $333.0M in total across 4 rounds, most recently a $100.0M Series B round in May 2026. Investors include Flagship Pioneering and Modi Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company